Therapeutic gold, silver, and platinum nanoparticles

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 3, 2015, Pages 428-445

  Yamada, Miko ^a   Foote, Matthew ^a,b   Prow, Tarl W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION; DISEASES; FIBER OPTIC SENSORS; GOLD; NANOPARTICLES; NANOSHELLS; PHOTOELECTRICITY; PLATINUM; RADIOTHERAPY; SILVER; TISSUE; TUMORS;

ELEMENTAL COMPOSITIONS; NANOPARTICLE TECHNOLOGIES; PHOTOELECTRIC CROSS-SECTIONS; PHOTOTHERMAL ABLATION; PLATINUM NANO-PARTICLES; SILVER NANOPARTICLES; THERAPEUTIC POTENTIALS; THERAPEUTIC STRATEGY;

METAL NANOPARTICLES;

ANTINEOPLASTIC AGENT; GOLD NANOPARTICLE; NANOSHELL; PLATINUM NANOPARTICLE; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; GOLD; HEAVY METAL; METAL NANOPARTICLE; PHOTOSENSITIZING AGENT; PLATINUM; SILVER;

ABLATION THERAPY; CANCER CELL; CROSS-SECTIONAL STUDY; DNA DAMAGE; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PHOTOMETRY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOSENSITIZATION; REVIEW; SUPERFICIAL CANCER; TEMPERATURE; THERAPY EFFECT; WOUND HEALING; ANIMAL; BACTERIAL INFECTIONS; CHEMISTRY; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; GOLD; HUMANS; METAL NANOPARTICLES; METALS, HEAVY; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLATINUM; SILVER;

EID: 84927164338     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1322     Document Type: Review

References (80)

1. Patnaik S, Gupta KC. Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv 2013, 10:215-228.
2. Ensign LM, Schneider C, Suk JS, Cone R, Hanes J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater 2012, 24:3887-3894.
3. Duceppe N, Tabrizian M. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv 2010, 7:1191-1207.
4. Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Controlled Release 2011, 149:65-71.
5. Kiriyama A, Iga K, Shibata N. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery. Ther Deliv 2013, 4:1261-1278.
6. Sridhar R, Ramakrishna S. Electrosprayed nanoparticles for drug delivery and pharmaceutical applications. Biomatter 2013, 3:pii:e24281. doi: 10.4161/biom.24281. (Epub March 19, 2013).
7. Tosi G, Bortot B, Ruozi B, Dolcetta D, Vandelli MA, Forni F, Severini GM. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr Med Chem 2013, 20:2212-2225.
8. Cheng R, Meng F, Deng C, Klok HA, Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013, 34:3647-3657.
9. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011, 63:470-491.
10. Geszke-Moritz M, Moritz M. Quantum dots as versatile probes in medical sciences: synthesis, modification and properties. Mater Sci Eng C Mater Biol Appl 2013, 33:1008-1021.
11. Petryayeva E, Algar WR, Medintz IL. Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging. Appl Spectrosc 2013, 67:215-252.
12. Probst CE, Zrazhevskiy P, Bagalkot V, Gao X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev 2013, 65:703-718.
13. Chang JC, Kovtun O, Blakely RD, Rosenthal SJ. Labeling of neuronal receptors and transporters with quantum dots. WIREs Nanomed Nanobiotechnol 2012, 4:605-619.
14. Gorris HH, Wolfbeis OS. Photon-upconverting nanoparticles for optical encoding and multiplexing of cells, biomolecules, and microspheres. Angew Chem 2013, 52:3584-3600.
15. Prow TW. Multiphoton microscopy applications in nanodermatology. WIREs Nanomed Nanobiotechnol 2012, 4:680-690.
16. Shen J, Zhao L, Han G. Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. Adv Drug Deliv Rev 2013, 65:744-755.
17. Sabella S. Impact of bionanointeractions of engineered nanoparticles for nanomedicine. In: Monteiro-Riviere NA, Tran CL, eds. Nanotoxicology: Progress Toward Nanomedicine. 2nd ed. Boca Raton, Florida, USA: CRC Press; 2014, 21-36.
18. Zhou HS, Honma I, Komiyama H, Haus JW. Controlled synthesis and quantum-size effect in gold-coated nanoparticles. Phys Rev B 1994, 50:12052-12056.
19. Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ. Nanoengineering of optical resonances. Chem Phys Lett 1998, 288:243-247.
20. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003, 100:13549-13554.
21. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005, 5:709-711.
22. Melancon MP, Lu W, Zhong M, Zhou M, Liang G, Elliott AM, Hazle JD, Myers JN, Li C, Stafford RJ. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials 2011, 32:7600-7608.
23. Kim J, Park S, Lee JE, Jin SM, Lee JH, Lee IS, Yang I, Kim JS, Kim SK, Cho MH, et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem 2006, 45:7754-7758.
24. Lim YT, Cho MY, Kim JK, Hwangbo S, Chung BH. Plasmonic magnetic nanostructure for bimodal imaging and photonic-based therapy of cancer cells. Chembiochem 2007, 8:2204-2209.
25. Pattani VP, Tunnell JW. Nanoparticle-mediated photothermal therapy: a comparative study of heating for different particle types. Lasers Surg Med 2012, 44:675-684.
26. Choi MR, Bardhan R, Stanton-Maxey KJ, Badve S, Nakshatri H, Stantz KM, Cao N, Halas NJ, Clare SE. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol 2012, 3:47-54.
27. Trinidad AJ, Hong SJ, Peng Q, Madsen SJ, Hirschberg H. Combined concurrent photodynamic and gold nanoshell loaded macrophage-mediated photothermal therapies: an in vitro study on squamous cell head and neck carcinoma. Lasers Surg Med 2014, 46:310-318.
28. Topete A, Alatorre-Meda M, Iglesias P, Villar-Alvarez EM, Barbosa S, Costoya JA, Taboada P, Mosquera V. Fluorescent drug-loaded, polymeric-based, branched gold nanoshells for localized multimodal therapy and imaging of tumoral cells. ACS Nano 2014, 8:2725-2738.
29. Herold DM, Das IJ, Stobbe CC, Iyer RV, Chapman JD. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 2000, 76:1357-1364.
30. Hainfeld JF, Foley CJ, Srivastava SC, Mausner LF, Feng NI, Meinken GE, Steplewski Z. Radioactive gold cluster immunoconjugates: potential agents for cancer therapy. Int J Radiat Appl Instrum B Nucl Med Biol 1990, 17:287-294.
31. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004, 49:N309-N315.
32. Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol 2005, 50:N163-N173.
33. Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy γ-/x-ray sources. Phys Med Biol 2009, 54:4889-4905.
34. Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X, Chen J, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009, 20:375101.
35. Kim JK, Seo SJ, Kim KH, Kim TJ, Chung MH, Kim KR, Yang TK. Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect. Nanotechnology 2010, 21:425102.
36. Roa W, Xiong Y, Chen J, Yang X, Song K, Yang X, Kong B, Wilson J, Xing JZ. Pharmacokinetic and toxicological evaluation of multi-functional thiol-6-fluoro-6-deoxy-D-glucose gold nanoparticles in vivo. Nanotechnology 2012, 23:375101.
37. Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One 2013, 8:e62425.
38. Joh DY, Kao GD, Murty S, Stangl M, Sun L, Al Zaki A, Xu X, Hahn SM, Tsourkas A, Dorsey JF. Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. Transl Oncol 2013, 6:722-731.
39. Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M, Geller DA. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 2008, 144:125-132.
40. Samberg ME, Loboa EG, Oldenburg SJ, Monteiro-Riviere NA. Silver nanoparticles do not influence stem cell differentiation but cause minimal toxicity. Nanomedicine 2012, 7:1197-1209.
41. Sabella S, Brunetti V, Vecchio G, Galeone A, Maiorano G, Cingolani R, Pompa PP. Toxicity of citrate-capped AuNPs: an in vitro and in vivo assessment. J Nanopart Res 2011, 13:6821-6835.
42. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118:407-413.
43. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008, 179:93-100.
44. Asharani PV, Lian WY, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19:255102.
45. Asharani PV, Low KMG, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
46. Tian J, Wong KK, Ho CM, Lok CN, Yu WY, Che CM, Chiu JF, Tam PK. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2:129-136.
47. Liu X, Lee PY, Ho CM, Lui VC, Chen Y, Che CM, Tam PK, Wong KK. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem 2010, 5:468-475.
48. Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33-37.
49. Kleinauskas A, Rocha S, Sahu S, Sun YP, Juzenas P. Carbon-core silver-shell nanodots as sensitizers for phototherapy and radiotherapy. Nanotechnology 2013, 24:325103.
50. Locatelli E, Naddaka M, Uboldi C, Loudos G, Fragogeorgi E, Molinari V, Pucci A, Tsotakos T, Psimadas D, Ponti J, et al. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (Lond) 2014, 9:839-849.
51. Gehrke H, Pelka J, Hartinger CG, Blank H, Bleimund F, Schneider R, Gerthsen D, Brase S, Crone M, Turk M, et al. Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations. Arch Toxicol 2011, 85:799-812.
52. Pelka J, Gehrke H, Esselen M, Turk M, Crone M, Brase S, Muller T, Blank H, Send W, Zibat V, et al. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chem Res Toxicol 2009, 22:649-659.
53. Porcel E, Liehn S, Remita H, Usami N, Kobayashi K, Furusawa Y, Le Sech C, Lacombe S. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology 2010, 21:85103. doi: 10.1088/0957-4484/21/8/085103. (Epub January 26, 2010).
54. Asharani PV, Xinyi N, Hande MP, Valiyaveettil S. DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine (Lond) 2010, 5:51-64.
55. Shi H, Ye XS, He XX, Wang KM, Cui WS, He DG, Li D, Jia XK. Au@Ag/Au nanoparticles assembled with activatable aptamer probes as smart "nano-doctors" for image-guided cancer thermotherapy. Nanoscale 2014, 6:8754-8761.
56. Yang P, Xu QZ, Jin SY, Lu Y, Zhao Y, Yu SH. Synthesis of multifunctional Ag@Au@phenol formaldehyde resin particles loaded with folic acids for photothermal therapy. Chemistry 2012, 18:9294-9299.
57. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011, 40:1647-1671.
58. Vecchio G, Galeone A, Brunetti V, Maiorano G, Sabella S, Cingolani R, Pompa PP. Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster. PLoS One 2012, 7:e29980. doi: 10.1371/journal.pone.0029980. (Epub January 4, 2012).
59. von Maltzahn G, Park JH, Lin KY, Singh N, Schwoppe C, Mesters R, Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater 2011, 10:545-552.
60. Liu X, Cao J, Li H, Li J, Jin Q, Ren K, Ji J. Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. ACS Nano 2013, 7:9384-9395.
61. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, Crowe TD, Nissen SE. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006, 48:833-838.
62. Kessentini S, Barchiesi D. Quantitative comparison of optimized nanorods, nanoshells and hollow nanospheres for photothermal therapy. Biomed Opt Expr 2012, 3:590-604.
63. Hawley L. Principles of radiotherapy. Br J Hosp Med 2013, 74:C166-C169.
64. Iwamoto KS, Cochran ST, Winter J, Holburt E, Higashida RT, Norman A. Radiation-dose enhancement therapy with iodine in rabbit Vx-2 brain-tumors. Radiother Oncol 1987, 8:161-170.
65. Cochran ST, Iwamoto K, Winter J, Norman A. Radiation-dose enhancement with iodine in brain-tumors. Med Phys 1986, 13:615-615.
66. Mello RS, Callisen H, Winter J, Kagan AR, Norman A. Radiation-dose enhancement in tumors with iodine. Med Phys 1983, 10:75-78.
67. Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg 2014, 133:49e-56e.
68. Regulla DF, Hieber LB, Seidenbusch M. Physical and biological interface dose effects in tissue due to X-ray-induced release of secondary radiation from metallic gold surfaces. Radiat Res 1998, 150:92-100.
69. Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 2013, 65:71-79.
70. Park JA, Reddy PA, Kim HK, Kim IS, Kim GC, Chang Y, Kim TJ. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent. Bioorg Med Chem Lett 2008, 18:6135-6137.
71. Glazer ES, Curley SA. Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes. Ther Deliv 2011, 2:1325-1330.
72. Rizzello L, Pompa PP. Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines. Chem Soc Rev 2014, 43:1501-1518.
73. Loomba L, Scarabelli T. Metallic nanoparticles and their medicinal potential. Part I: gold and silver colloids. Ther Deliv 2013, 4:859-873.
74. Mijnendonckx K, Leys N, Mahillon J, Silver S, Van HR. Antimicrobial silver: uses, toxicity and potential for resistance. Biometals 2013, 26:609-621.
75. Samberg ME, Orndorff PE, Monteiro-Riviere NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5:244-253.
76. Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M. Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol 2014, 98:1951-1961.
77. 2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 2009, 22:266-275.
78. Ding H, Yong KT, Roy I, Hu R, Wu F, Zhao L, Law WC, Zhao W, Ji W, Liu L, et al. Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers. Nanotechnology 2011, 22:165101.
79. Rosenberg B, Vancamp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965, 205:698-699.
80. Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature 1969, 222:385-386.